National Breast Cancer and Lymphedema Registry
18 Years
N/A
Both
Breast Cancer, Lymphedema
Trial Information
National Breast Cancer and Lymphedema Registry
Historically, breast cancer-associated lymphedema has been relatively ignored, with
mis-diagnosis, late diagnosis, and failure to treat. The condition has a measurable,
substantial impact on patient function and perceived quality of life (QOL). Recent pilot
studies suggest that interventions that are designed to facilitate early diagnosis and
preventive strategies have a major impact on the incidence and severity of disease burden.
This registry is designed to prospectively capture the relevant data to document the impact
of preemptive diagnostic and treatment strategies.
Inclusion Criteria:
- Breast cancer survivorship
Exclusion Criteria:
- Age < 18 years old
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Preemptive diagnostic and treatment strategies
Outcome Description:
The methods for lymphedema surveillance and detection will be correlated to the new appearance of lymphedema in this cohort of breast cancer survivors. We will also assess severity of lymphedema and responsiveness to treatment strategies.
Outcome Time Frame:
Each enrolled patient will be followed for an average of 1 year
Safety Issue:
No
Principal Investigator
Stanley G Rockson
Investigator Role:
Principal Investigator
Investigator Affiliation:
Stanford University
Authority:
United States: Institutional Review Board
Study ID:
SU-10042011-8529
NCT ID:
NCT01580800
Start Date:
September 2011
Completion Date:
December 2025
Related Keywords:
- Breast Cancer
- Lymphedema
- Breast Neoplasms
- Lymphedema
Name | Location |
|---|---|
| Stanford University School of Medicine | Stanford, California 94305-5317 |
